Sources & references Frontiers in Pharmacology Stable Gastric Pentadecapeptide BPC 157 and Wound Healing Seiwerth S, Milavic M, Vukojevic J, et al
What the Research Says About Safety Clinical studies on AOD9604 indicate that the peptide is generally welltolerated: In human trials, no significant adverse effects were reported at doses up to 1 mg/day (safety summary) Unlike growth hormone therapies, AOD9604 does not meaningfully elevate IGF1 levels (human data), which may reduce the risk of unwanted growthrelated side effects
Water, milk, semi-liquid dairy products or a dairy substitute are all appropriate to thoroughly mix ImmunoPro
The cells respond immediately and robustly to receptor activation
Aspirin provides antiplatelet protection, while tirzepatide has been associated with improvements in cardiovascular risk markers such as blood pressure, cholesterol, and body weight